Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease
Wenli Zhao, Yue Liu, Lijuan Xu, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 12, pp. 1697-1713
Closed Access | Times Cited: 19

Showing 19 citing articles:

Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases
Rohan Gupta, Kumari Smita, Rahul Tripathi, et al.
Ageing Research Reviews (2023) Vol. 86, pp. 101855-101855
Closed Access | Times Cited: 14
Targeting Receptor-Interacting Protein Kinase 1 by Novel Benzothiazole Derivatives: Treatment of Acute Lung Injury through the Necroptosis Pathway
Xinqi Zhang, Qianyu Han, Ruilin Hou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5261-5278
Closed Access | Times Cited: 13
Development and Evaluation in Rat and Monkey of a Candidate Homochiral Radioligand for PET Studies of Brain Receptor Interacting Protein Kinase 1: [18F](S)-1-(5-(3-Fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)-2,2-dimethylpropan-1-one
Susovan Jana, Mudasir Maqbool, Xuefeng Yan, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Network pharmacology exploring the mechanistic role of indirubin phytoconstituent from Indigo naturalis targeting GSK-3 β in Alzheimer’s disease
Hitesh Kumar, Ashok Kumar Datusalia, Anoop Kumar, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-14
Closed Access
Targeting necroptosis in Alzheimer’s disease: can exercise modulate neuronal death?
Di Lu, Wenyu Zhang, Ruiyu Li, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Necroptosis in myocardial ischaemia-reperfusion injury: current update on mechanisms, therapeutic targets, and translational potential
Siarhei A. Dabravolski, Vladislav Kalmykov, Anastasia O Maksaeva, et al.
APOPTOSIS (2025)
Closed Access
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
Yi Sun, Lijuan Xu, Hongming Shao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14957-14969
Closed Access | Times Cited: 17
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
Lijuan Xu, Wannian Zhang, Chunlin Zhuang
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 2, pp. 101-124
Closed Access | Times Cited: 10
Analysis and experimental validation of necroptosis-related molecular classification, immune signature and feature genes in Alzheimer’s disease
Piaopiao Lian, Cai Xing, Xiaoman Yang, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 726-742
Open Access | Times Cited: 3
Profiling of small‐molecule necroptosis inhibitors based on the subpockets of kinase–ligand interactions
Lijuan Xu, Chunlin Zhuang
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1974-2024
Closed Access | Times Cited: 8
Structure-Based Design of Novel Alkynyl Thio-Benzoxazepinone Receptor-Interacting Protein Kinase-1 Inhibitors: Extending the Chemical Space from the Allosteric to ATP Binding Pockets
Danni Quan, Ruilin Hou, Hongming Shao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 3073-3087
Closed Access | Times Cited: 6
Paradoxical roles for programmed cell death signaling during viral infection of the central nervous system
Juan P. Angel, Brian P. Daniels
Current Opinion in Neurobiology (2022) Vol. 77, pp. 102629-102629
Open Access | Times Cited: 9
Role of Necroptosis in Central Nervous System Diseases
Hongming Shao, Wenbin Wu, Pei Wang, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 23, pp. 3213-3229
Closed Access | Times Cited: 9
Preclinical Evaluation of Dihydropyrazole-Cored Positron Emission Tomography (PET) Ligands for Imaging of Receptor-Interacting Serine/Threonine Protein Kinase 1 (RIPK1) in the Brain
Wanqing Li, Xiaojun Zhang, Jie Ma, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Structure-Based Discovery of a 4,5-Dihydropyrazole-Cored PET Ligand for Imaging of Receptor-Interacting Serine/Threonine-Protein Kinase 1 (RIPK1) in the Brain
Wanqing Li, Xiaojun Zhang, Jingyin Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116803-116803
Closed Access | Times Cited: 1
Profiling of the chemical space on the phenyl group of substituted benzothiazole RIPK3 inhibitors
Yue Xu, Caiquan Liang, Wannian Zhang, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106339-106339
Closed Access | Times Cited: 7
A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
Zilu Meng, Wenhan Yang, Lei Zhu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 1
Discovery of potential RIPK1 inhibitors by machine learning and molecular dynamics simulations
Jixiang Liu, Risong Na, Lianjuan Yang, et al.
Physical Chemistry Chemical Physics (2023) Vol. 25, Iss. 45, pp. 31418-31430
Closed Access
RECENT DEVELOPMENTS IN THE DISCOVERY OF BRAIN-PENETRANT RIP1 INHIBITORS
Craig E. Stivala, Domagoj Vucic
Medicinal chemistry reviews (2023), pp. 83-102
Closed Access
Page 1

Scroll to top